Compare Nuvalent Inc (NUVL) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Western Alliance Bancorporation — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Western Alliance Bancorporation trades at $79.8 (market cap $8.84B). The key difference: Nuvalent Inc and Western Alliance Bancorporation are close in size by market cap, and Western Alliance Bancorporation pays a 2.07% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | WAL | |
|---|---|---|
Market Cap | $9.81B | $8.84B |
Sector | Technology | Financials |
52-Week High | $123.96 | $96.08 |
52-Week Low | $72.16 | $66.70 |
Enterprise Value | $8.52B | — |
Dividend Yield | — | 2.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
